EN DE

Dhampur Bio Organics Limited (DBOL) Fair Value & Analysis

Consumer Defensive · IN · Market cap ₹7.4B

DB Dhampur Bio Organics Limited DBOL · NSE
Price₹114.11
Fair Value₹65.43
Upside-42.7%
Quality55/100
Watch Dhampur Bio Organics Limited for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Thin margins · 1.2% net margin
Low debt · generates free cash flow
1.34% dividend yield
Mixed vs. peers (6/14)
Narrow moat 33/100
Evidence: High Range ₹48.80 – ₹81.33 Share as image

Fair value as of: Aug 2, 2026

From 25 valuation models · updated 11 days ago

Share price −0.5% over the past month.

A solid business, but screening 43% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (₹81.33). The favourable scenario is already priced in.
  • Solid but not exceptional quality (55/100) and above fair value, neither a clear bargain nor a standout compounder.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (4 years)

₹205.62 ₹58.42 Fair Value ₹65.43 Sep 2022 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 2, 2026.

How to read this chart

47‑month range ₹58.42 – ₹205.62 · fair‑value band ₹48.80 – ₹81.33 · the ₹114.11 price screens above the ₹65.43 fair value. Dashed = 300-day average. As of Aug 2, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Dhampur Bio Organics Limited (DBOL) currently trades at ₹114.11, while our model-based Fair Value estimate is ₹65.43, implying the stock looks roughly 42.7% overvalued today. The Quality Score stands at 55/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Dhampur Bio Organics Limited generated revenue of ₹21.1B at a net margin of 1.2%. Revenue grew 16.2% year over year. It earns a return on equity of 2.5%. Net debt stands at ₹10.2B. Fundamentals as of Aug 2, 2026

Our scenario range runs from ₹48.80 (bear case) to ₹81.33 (bull case); at ₹114.11, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 13% below its 52-week high and 65% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at 102% fair-value upside, at -43%, DBOL screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF ₹156.05 ₹224.71 ₹314.63 80
Residual Income ₹109.53 ₹104.39 ₹83.17 76
Rev-Margin DCF ₹99.11 ₹153.27 ₹212.34 74
All 25 models by family
DCF Models
FCF DCF ₹151.60 ₹226.16 ₹328.31 38
Owner Earnings ₹35.30 ₹61.03 ₹96.28 31
5Y Revenue Exit ₹99.11 ₹150.55 ₹212.64 39
5Y EBITDA Exit ₹146.71 ₹235.38 ₹333.99 41
5Y P/E Exit ₹73.71 ₹105.29 ₹135.80 38
10Y Revenue Exit ₹115.07 ₹164.20 ₹223.08 36
10Y EBITDA Exit ₹146.93 ₹220.32 ₹309.68 37
10Y P/E Exit ₹102.29 ₹134.26 ₹168.25 35
Earnings-Based
Graham-Dodd ₹26.03 ₹61.97 ₹79.90 54
PEG = 1.0 ₹10.80 ₹15.42 ₹20.05 46
EPV ₹51.87 ₹64.16 ₹74.77 59
Dividend Discount
Gordon GGM ₹11.08 ₹18.83 ₹27.89 70
DDM Multi-Stage ₹11.08 ₹16.22 ₹21.64 61
Multiples
P/E Multiple ₹60.28 ₹80.38 ₹100.47 63
P/S Multiple ₹48.80 ₹65.07 ₹81.33 58
P/B Multiple ₹48.80 ₹65.07 ₹81.33 55
EV/EBIT ₹113.67 ₹160.21 ₹206.76 53
EV/EBITDA ₹167.97 ₹232.62 ₹297.26 54
EV/Revenue ₹73.70 ₹116.41 ₹159.12 43
Asset-Based
NCAV (Graham) ₹78.03 ₹104.55 ₹156.05 50
Growth DCF
Growth DCF ₹156.05 ₹224.71 ₹314.63 80
Rev-Margin DCF ₹99.11 ₹153.27 ₹212.34 74
Economic Profit
Residual Income ₹109.53 ₹104.39 ₹83.17 76
ROIC Compounder ₹51.87 ₹64.16 ₹74.77 72
Growth Earnings
Growth-Adj P/E ₹45.80 ₹65.43 ₹85.05 68

Widest divergence: Growth DCF (₹153.27) versus Dividend Discount (₹16.22). Highest evidence: Growth DCF (80).

Notify me when DBOL reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) ₹21.1B
Revenue growth (YoY) +16.2%
Net margin 1.2%
Return on equity 2.5%
Free cash flow ₹1.1B FY2026
P/E ratio 29.5
More key figures
Operating margin 14.9%
EPS (TTM) ₹3.80
Dividend yield 1.3%
EPS growth (YoY) +3.4%
Net debt ₹10.2B FY2026

Figures from reported company fundamentals · as of Aug 2, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 55/100

Of which business quality 53 · Market factors (momentum, volatility) 67

Profitability 31
Margins and returns on capital today
Quality Growth 51
Are margins and returns improving?
Cashflow 58
Earnings quality: real cash, not paper profit
Fin. Strength 30
Balance sheet, leverage, solvency risk
Investment 91
Disciplined investing over empire-building
Low Volatility 69
Calm price path (market factor)
Momentum 63
Price trend over the last 3–12 months (market factor)
52W Momentum 73
Distance to the 52-week high (market factor)
Net Issuance 84
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Dhampur Bio Organics Limited, an integrated sugarcane processing company, engages in the manufacture and sale of refined, sulphitation, raw sugar, sugar, biomass-based renewable power, biofuels, potable liquor, chemicals, and allied products in India. The company operates through three segments: Sugar, Bio Fuels & Spirits, and Country Liquor.

Full company description

Dhampur Bio Organics Limited, an integrated sugarcane processing company, engages in the manufacture and sale of refined, sulphitation, raw sugar, sugar, biomass-based renewable power, biofuels, potable liquor, chemicals, and allied products in India. The company operates through three segments: Sugar, Bio Fuels & Spirits, and Country Liquor. It also offers alcoholic beverages with 25% and 36% alcohol content; and ENA, a food-grade alcohol, as well as bagasse and organic fertilizer. In addition, the company manufactures and sells SDS, ethanol, sanitizer, etc., as well as engages in the co-generation and sale of power. The company also exports its products. Dhampur Bio Organics Limited was incorporated in 2020 and is based in New Delhi, India.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Dhampur Bio Organics Limited reported revenue of ₹21.1B in FY2026 versus ₹15.5B in FY2022, a compound +7.9%/yr. Reported net income was ₹252M in FY2026, compounding −29.6%/yr from FY2022.

Growth Quality 40/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2026)
₹21.1B
Latest YoY
+13.3%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−4.3%
Revenue +7.9%/yr
FY22 ₹15.5B
FY23 ₹24.1B
FY24 ₹18.4B
FY25 ₹18.6B
FY26 ₹21.1B
Net income −29.6%/yr
FY22 ₹1.0B
FY23 ₹1.1B
FY24 ₹465M
FY25 ₹147M
FY26 ₹252M

DBOL screens 43% overvalued. Compare with Muyuan Foods Group →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Dhampur Bio Organics Limited Fair Value". https://www.fairvalue-calculator.com/stock/DBOL

Peer Group

Farm Products · 290 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 55 · Above median
Fair Value upside −43% · Below median
Return on equity (TTM) 2% · Below median
Return on assets 2% · Below median
Net margin (TTM) 1% · Below median
Operating margin (TTM) 15% · Top 25%
Revenue growth 16% · Above median
Dividend yield (TTM) 1.3% · Below median
Debt / equity 0.20× · Higher than median

Valuation Multiples vs Farm Products median · lower = cheaper

P/E (TTM) 29.5× · Pricier than 75% of peers
P/B 0.72× · Cheaper than median
P/S (TTM) 0.35× · Cheaper than median
P/FCF 0.1× · Cheaper than 75% of peers
EV/EBITDA 6.9× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 25
FUTURE 81 · sector 20
PAST 10 · sector 17
HEALTH 90 · sector 94
DIVIDEND 27 · sector 38

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Farm Products stocks, each showing price versus our Fair Value estimate (as of Aug 2, 2026).

Stock Price Fair Value vs Fair Value
Muyuan Foods Group 002714 ¥40.90 ¥48.19 +18%
Wens Foodstuff Group 300498 ¥14.51 ¥12.08 -17%
Mowi ASA MOWI kr 188.40 kr 262.59 +39%
PT Charoen Pokphand Indonesia Tbk, CPIN 3,120 IDR 7,076 IDR +127%
Charoen Pokphand Foods Public Company CPF 22.00 THB 55.71 THB +153%
PT Triputra Agro Persada Tbk TAPG 1,540 IDR 3,105 IDR +102%
PT FAP Agri Tbk FAPA 7,300 IDR 7,463 IDR +2%
PT Japfa Comfeed Indonesia Tbk JPFA 2,070 IDR 7,231 IDR +249%
Thaifoods Group TFGR 10.60 THB 23.53 THB +122%
PT Jhonlin Agro Raya Tbk JARR 1,845 IDR 610.80 IDR -67%

Compare Dhampur Bio Organics Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Dhampur Bio Organics Limited (DBOL) overvalued or undervalued?
As of Aug 2, 2026, our model estimates a fair value of ₹65.43 versus a price of ₹114.11, about −43% (overvalued).
What is the fair value of DBOL?
Our model-based fair value for Dhampur Bio Organics Limited is ₹65.43 (as of Aug 2, 2026), built from audited fundamentals. The current price is ₹114.11.
What is the quality score of DBOL?
Dhampur Bio Organics Limited has a Quality Score of 55/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Dhampur Bio Organics Limited (DBOL)?
Dhampur Bio Organics Limited reported trailing-twelve-month revenue of about ₹21.1B (latest available figure, as of Aug 2, 2026).
What is the net profit margin of DBOL?
The net profit margin of Dhampur Bio Organics Limited is about 1.2%, meaning it keeps roughly 1.2% of revenue as net income. Based on the latest reported figures.
Does Dhampur Bio Organics Limited pay a dividend?
Dhampur Bio Organics Limited currently shows a dividend yield of about 1.34% relative to its recent price (as of Aug 2, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Dhampur Bio Organics Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.